Suchen
Inventiva SA
IVAZur Watchlist hinzufügen
3.260USD
-0.190-5.51%
Handelsschluss 09-23 16:00（ET）
770.13MMarktkapitalisierung
0.00KGV TTM
Über Inventiva SA Unternehmen
Inventiva SA is a France-based company engaged in the biotechnology sector. The Company focuses on the development of therapies in the area of oncology, fibrosis and rare diseases. The Company’s pipeline comprises a number of development programs, such as Clinical Pipeline, Preclinical Pipeline, AbbVie Collaboration and Boehringer-Ingelheim collaboration. Its drug candidates target at the treatment of non-alcoholic steatohepatitis (NASH), systemic sclerosis (SSc), various types of mucopolysaccharidosis (MPS), multiple myeloma, auto-immune disorders, as well as lung cancer, among others. In addition, the Company offers drug discovery services, ranging from target identification to preclinical nomination, in numerous areas, such as silico modelling, biology, screening, absorption, distribution, metabolism and excretion (ADME), pharmacology and histology.
Inventiva SA Profil
BörsenkürzelIVA
Name des UnternehmensInventiva SA
IPO-datumFeb 15, 2017
CEOObenshain (Andrew)
Anzahl der mitarbeiter- -
WertpapierartDepository Receipt
Geschäftsjahresende- -
Addresse50 rue de Dijon
StadtDAIX
BörseNASDAQ OMX - NASDAQ BASIC
LandFrance
Postleitzahl21121
Telefon33380447500
Websitehttps://inventivapharma.com/
BörsenkürzelIVA
IPO-datumFeb 15, 2017
CEOObenshain (Andrew)
Führungskräfte von Inventiva SA
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Andre Turenne
Mr. Andre Turenne
Independent Director
Independent Director
--
--
Mr. Andrew Obenshain
Mr. Andrew Obenshain
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Christopher (Chris) Benecchi
Mr. Christopher (Chris) Benecchi
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jean Volatier
Mr. Jean Volatier
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nathalie Harroy
Ms. Nathalie Harroy
Director - Human Resources
Director - Human Resources
--
--
Ms. Martine Zimmerman
Ms. Martine Zimmerman
Independent Director
Independent Director
--
--
Dr. Annick Schwebig, M.D.
Dr. Annick Schwebig, M.D.
Independent Director
Independent Director
--
--
Mr. Heinz Maeusli
Mr. Heinz Maeusli
Independent Director
Independent Director
--
--
Mr. Eric Duranson
Mr. Eric Duranson
General Counsel
General Counsel
--
--
Ms. Pascaline Clerc
Ms. Pascaline Clerc
Executive Vice President - Strategy and Corporate Affairs
Executive Vice President - Strategy and Corporate Affairs
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Andre Turenne
Mr. Andre Turenne
Independent Director
Independent Director
--
--
Mr. Andrew Obenshain
Mr. Andrew Obenshain
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Christopher (Chris) Benecchi
Mr. Christopher (Chris) Benecchi
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jean Volatier
Mr. Jean Volatier
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nathalie Harroy
Ms. Nathalie Harroy
Director - Human Resources
Director - Human Resources
--
--
Ms. Martine Zimmerman
Ms. Martine Zimmerman
Independent Director
Independent Director
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Inventiva SA?
Die fünf größten Anteilseigner von Inventiva SA sind: Mr. Andre Turenne
Wie viele Institutionen halten Anteile an Inventiva SA (IVA)?
Mit Stand vom 2026Q1 halten 63 Institutionen Anteile an Inventiva SA, mit einem Gesamtmarktwert von etwa 49.29M, was 25.51% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 35581870.00 gestiegen.